Cognition Therapeutics, Inc. (CGTX) vs LENSAR Inc (LNSR)
A side-by-side comparison of Cognition Therapeutics, Inc. and LENSAR Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT
LNSR
LENSAR Inc
$6.66HealthcareDelayed quote: Oct 6, 2026, 10:06 AM EDT
Total return — CGTX vs LNSR
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)LNSR -12.4% (-2.6%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
CGTX LNSR
CGTX vs LNSR: by the numbers
- •CGTX is the larger company ($85M vs $82M market cap).
- •LNSR is profitable (57.57% net margin) while CGTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CGTX | LNSR |
|---|---|---|
| P/S ratio | N/A | 1.36 |
| P/B ratio | 2.57 | 5.49 |
Profitability
| Metric | CGTX | LNSR |
|---|---|---|
| Gross margin | 0.00% | 47.96% |
| Operating margin | 0.00% | -42.06% |
| Net margin | 0.00% | 57.57% |
| ROE | -50.80% | 232.78% |
| ROIC | -109.43% | -16.28% |
Growth (annualized)
| Metric | CGTX | LNSR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 14.67% |
| Total return CAGR (5Y) | N/A | -3.18% |
Frequently asked
- Is CGTX or LNSR more profitable?
- LNSR runs the higher net margin — CGTX at 0.00% versus LNSR at 57.57%.
Go deeper
Dig into the metrics
Cognition Therapeutics ROELENSAR ROECognition Therapeutics operating marginLENSAR operating marginCognition Therapeutics revenue growthLENSAR revenue growthCognition Therapeutics free cash flowLENSAR free cash flow
Cognition Therapeutics & LENSAR appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.